J&J UK Launches Public-Private iDx-Lung Consortium to Improve Early Detection of Lung Cancers The Universities of Southampton and Leeds will lead the project with participation from Johnson & Johnson, Roche, Oncimmune, BC Platforms, Inivata, and NHS England. AnchorDx, Johnson & Johnson Collaborate on Early-Stage Lung Cancer Diagnosis Study The collaborators aim to develop lung cancer molecular diagnostic tests using molecular, clinical, and imaging-based artificial intelligence technologies. Envisagenics to Bring RNA Splicing Software Platform to J&J Lung Cancer Initiative The Cold Spring Harbor Laboratory spinout will build predictive models for lung cancer progression and risk using its SpliceCore software platform. Thermo Fisher, Janssen Biotech to Develop CDx for Lung Cancer, Other Indications The companies initially plan to validate biomarkers for use with the Oncomine Dx Target Test to identify NSCLC patients for enrollment into clinical trials. UK Biobank Whole-Genome Sequencing Project Obtains £200M from Pharma, Government, Philanthropy The project is funded with £50 million from the UK government, £50 million from the Wellcome Trust, and £100 million from four pharmaceutical firms. Jan 3, 2019 Veracyte, Johnson & Johnson Innovation Collaborate on Lung Cancer Dx Jul 10, 2018 Cue Health Closes $45M Series B Financing Jun 22, 2018 In Brief This Week: Baby Genes, J&J Innovation, Myriad Genetics, Merck, More Jun 6, 2018 J&J, BU Partner on Multi-Year Lung Cancer Detection Initiative Dec 6, 2017 UK Government Commits £210M to Grow Life Science Sector Dec 12, 2016 Ortho Adopts Startup Culture with Intense Dx Focus After Spin Off from J&J Premium Feb 4, 2016 Cue Partners With J&J's Janssen Pharma on HIV Viral Load Assay Jul 15, 2015 Study Detects PD-L1 Expression on Breast Cancer Patient CTCs, Points to Potential New CellSearch Use Premium May 13, 2015 Janssen Diagnostics, Biocartis Collaboration Yields Prototype HCV, Flu/RSV, Flu Surveillance Tests Premium Jun 27, 2013 Janssen, Icahn School of Medicine to Investigate IBD Jun 6, 2013 Startup Arcturus Pulls in $1.3M in Seed Money amid Renewed Interest in RNAi Premium Jun 5, 2013 Second Genome Inks Development Deal with Janssen; Raises Additional $6.5M May 3, 2013 Australian Team Developing Plasma Protein Panel for Predicting Amyloid Burden in Alzheimer's Patients Premium Apr 22, 2013 OICR to Launch Prostate Marker Clinical Trials with Janssen Apr 17, 2013 J&J Tests WGS of Rheumatoid Arthritis Patients to ID Markers of Drug Response, Predisposition Genes Premium Jan 18, 2013 LabCorp Offering Veridex's CTC Test for Clinical Trials Research in China Dec 20, 2012 Australia's SpeeDx Demonstrates Multiplexed MNAzyme qPCR; Looks to Move Tech to MDx Market Premium Dec 13, 2012 China Approves Veridex's CellSearch Test for Metastatic Breast Cancer Oct 10, 2012 People in the News: Roy Davis, Peter Maag Premium Sep 27, 2012 In Its Third Phase, the RNAi Consortium Looks to ncRNAs, Gene Over-Expression Premium Load More Breaking News Thermo Fisher Scientific Next-Generation SARS-CoV-2 PCR Test Nabs CE-IVD Mark Cytosine Base Editor Enables Genome-Wide Genetic Function Screening G42 Healthcare, Seegene to Offer Mobile Molecular Diagnostic Labs in Middle East, North Africa JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems Top Five Articles on GenomeWeb Last Week: Danaher, Becton Dickinson, 23andMe, and More Berry Oncology, Alibaba Health Partner to Offer Early Cancer Screening, Health Services The Scan Renewed Gain-of-Function Worries The New York Times writes that the pandemic is renewing concerns about gain-of-function research. Who's Getting the Patents? A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports. Other Uses CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2. PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.